首页> 美国卫生研究院文献>Global Pediatric Health >No Time for Lullabies Tracing down Pharmacological Effects Uses of H1-Antihistamines in Children Younger than 6 Years
【2h】

No Time for Lullabies Tracing down Pharmacological Effects Uses of H1-Antihistamines in Children Younger than 6 Years

机译:没有时间追查于6岁以下儿童H1-Antiamines的药理作用和使用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objectives. To provide a qualitative and a quantitative analysis of H1-antihistamines pharmacological uses pattern among children (<6 years old) and to evaluate the parental-related awareness. Methods. A cross-sectional study was carried out at 5 retail pharmacies in Jordan over 5 months (October/2019-February/2020). Parents who requested any of H1-antihistmine agent for a child (<6 years) were invited to participate. Results. A total of 516 children, most of them were toddlers (1-3) years, received at least 1 H1-antihistamine. More than half of the cases received H1-antihistamine as self-medication (56.3%). Sedating antihistamine agents were the most frequently used among children (<6 years old) (77.9%) among which Chlorpheniramine maleate was the most commonly used agent (62.9%). About half of the children (47.0%) received H1-antihistamine to induce sleep. Whereas, 21.7% and 12.9% received them to manage flu, and allergic rhinitis (AR), respectively. Around 66.6% of the cases were classified as off-label use. Most of the parents (80.5%) were aware of the sedative adverse effects of H1-antihistamines, whereas a fewer number (31.9%) were aware of their cognitive effects. Finally, more than two thirds of parents (79.7%) were unfamiliar with off-label drug use in children. Conclusion. Despite the availability of less-sedating H1-antihistamines with a wide safety and efficacy record, the use of sedating H1-antihistamines remains popular in children.
机译:目标。为了提供儿童(<6岁)的H1-抗组胺药药理的定性和定量分析,并评估与父母有关的认识。方法。在约旦5个月(2019年2月/ 2020年)的约旦零售药房中进行了横断面研究。请求要求任何H1-Antihistmine代理人(<6年)的父母参加。结果。共有516名儿童,大多数是幼儿(1-3)年,至少收到至少1 H1-抗组胺药。超过一半的病例接受了H1-抗组胺药作为自我药物(56.3%)。镇静抗组胺药剂是儿童(<6岁)(77.9%)中最常使用的抗组胺药剂(77.9%)中,其中氯苯那三明氨酸马来酸是最常用的药剂(62.9%)。大约一半的孩子(47.0%)接受了H1-抗组胺药以诱导睡眠。虽然,21.7%和12.9%,分别获得流感和过敏性鼻炎(AR)。大约66.6%的病例被归类为低标签使用。大多数父母(80.5%)都意识到H1-抗组胺药的镇静不良影响,而数量少(31.9%)意识到其认知效果。最后,超过三分之二的父母(79.7%)不熟悉儿童用药药物使用。结论。尽管具有广泛的安全性和疗效记录的H1-抗组胺药的可用性,但镇静H1-抗组胺药的使用在儿童中仍然受欢迎。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号